广州白云山医药集团股份有限公司（股票代码：00874）于2026年7月2日发布2026年6月股份变动月报表。公告显示，截至2026年6月30日，公司已发行股份及注册股本未发生新增发行、购回、注销或库藏股变动。
根据报告披露，白云山的已发行H股股份数量为219,900,000股，A股股份数量为1,405,890,949股，两类股份合计本月底仍维持在1,625,790,949股，与上月底数值一致。公司表示，本期无新增股份期权、股权激励或可转债，亦无回购或注销安排。
公司同时确认，已遵守香港联交所《上市规则》及相关法律法规的要求。本次公告由公司秘书黄雪贞签署。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.